These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 207962)

  • 21. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
    Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
    Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cyclic progestin-estrogen therapy on sebum and acne in women.
    Strauss JS; Pochi PE
    JAMA; 1964 Nov; 190(9):815-9. PubMed ID: 12254865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hypertension with irreversible renal failure due to oral contraceptives.
    Zech P; Rifle G; Lindner A; Sassard J; Blanc-Brunat N; Traeger J
    Br Med J; 1975 Nov; 4(5992):326-7. PubMed ID: 1192051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oral contraceptive on liver function tests of women with schistosomiasis in the Philippines.
    Sy FS; Osteria TS; Opiniano V; Gler S
    Contraception; 1986 Sep; 34(3):283-94. PubMed ID: 3098499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma in women: probable lack of etiologic association with oral contraceptive steroids.
    Goodman ZD; Ishak KG
    Hepatology; 1982; 2(4):440-4. PubMed ID: 6284630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of hepatoma in pregnancy associated with earlier oral contraception.
    Christensen SE; Andersen VR; Vilstrup H
    Acta Obstet Gynecol Scand; 1981; 60(5):519. PubMed ID: 6272530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liver cell carcinoma associated with oral contraceptives (author's transl)].
    Leclère J; Meot B; Marchal F; Mizrahi R; Collard F; Rauber G; Hartemann P
    Ann Endocrinol (Paris); 1977; 38(6):361-2. PubMed ID: 206178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible association between benign hepatomas and oral contraceptives.
    Baum JK; Bookstein JJ; Holtz F; Klein EW
    Lancet; 1973 Oct; 2(7835):926-9. PubMed ID: 4126557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of 35 mcg and 50 mcg combined oral contraceptives: results from a multicenter clinical trial.
    McLaurin VL; Dunson BA; Dunson TR
    Contraception; 1991 Nov; 44(5):489-503. PubMed ID: 1797464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Effort thrombosis" of the subclavian vein associated with oral contraceptives.
    Stricker SJ; Sowers DK; Sowers JR; Sirridge MS
    Ann Emerg Med; 1981 Nov; 10(11):596-9. PubMed ID: 7316265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver tumor in long-term user of oral contraceptives.
    Ferrara BE; Rutland ED
    Postgrad Med; 1988 Nov; 84(6):107-9. PubMed ID: 2847128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver cell adenoma and oral contraceptives. Double tumor development.
    Antoniades K; Campbell WN; Hecksher RH; Kessler WB; McCarthy GE
    JAMA; 1975 Nov; 234(6):628-9. PubMed ID: 170431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.